Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2009 Apr 18;11(3):209–215. doi: 10.1007/s11908-009-0031-5

Prophylaxis against pulmonary viral and fungal infections in solid organ transplant recipients

Anton Y Peleg 1,✉, Mary T LaSalvia, Eleftherios Mylonakis, Fernanda P Silveira
PMCID: PMC7089285  PMID: 19366563

Abstract

Pulmonary viral and fungal infections in solid organ transplant recipients are one of the most common and potentially life-threatening infections. Understanding the strategies used for prophylaxis and prevention of these infections is critical for the health and well-being of transplant recipients. Prophylactic measures range from simple patient education to complex chemoprophylactic interventions; however, a multifaceted approach is most often required. This article focuses on strategies to prevent pulmonary viral and fungal infections in transplant recipients, with an emphasis on recent evidence that may influence practice guidelines.

Keywords: Transplant Recipient, Respiratory Syncytial Virus, Voriconazole, Oseltamivir, Invasive Aspergillosis

References and Recommended Reading

  • 1.Barton T.D., Blumberg E.A. Viral pneumonias other than cytomegalovirus in transplant recipients. Clin Chest Med. 2005;26:707–720. doi: 10.1016/j.ccm.2005.06.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Community-acquired respiratory viruses. Am J Transplant 2004, 4(Suppl 10):105–109. [DOI] [PMC free article] [PubMed]
  • 3.Hopkins P., McNeil K., Kermeen F., et al. Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus. Am J Respir Crit Care Med. 2008;178:876–881. doi: 10.1164/rccm.200711-1657OC. [DOI] [PubMed] [Google Scholar]
  • 4.Adenovirus. Am J Transplant 2004, 4(Suppl 10):101–104. [DOI] [PubMed]
  • 5.Ison M.G., Hayden F.G. Viral infections in immunocompromised patients: what’s new with respiratory viruses? Curr Opin Infect Dis. 2002;15:355–367. doi: 10.1097/00001432-200208000-00002. [DOI] [PubMed] [Google Scholar]
  • 6.Fishman JA: Common pulmonary infections in immunocompromised patients. Up to Date Online, 2007. Available at http://www.uptodate.com/online/content/topic.do?topicKey=immuninf/5252&selectedTitle=2:_150&source=search_result. Accessed January 2009.
  • 7.Vilchez R.A., Fung J., Kusne S. The pathogenesis and management of influenza virus infection in organ transplant recipients. Transpl Infect Dis. 2002;4:177–182. doi: 10.1034/j.1399-3062.2002.t01-4-02001.x. [DOI] [PubMed] [Google Scholar]
  • 8.Vilchez R.A., Dauber J., McCurry K., et al. Parainfluenza virus infection in adult lung transplant recipients: an emergent clinical syndrome with implications on allograft function. Am J Transplant. 2003;3:116–120. doi: 10.1034/j.1600-6143.2003.00024.x. [DOI] [PubMed] [Google Scholar]
  • 9.Siegel JD, Rhinehart E, Jackson M, Chiarello L, and the Healthcare Infection Control Practices Advisory Committee: 2007 Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings, June 2007. Available at http://www.cdc.gov/ncidod/dhqp/pdf/isolation2007.pdf. Accessed January 2009. [DOI] [PMC free article] [PubMed]
  • 10.Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 2004, 4(Suppl 10):160–163. [DOI] [PubMed]
  • 11.Fiore A.E., Shay D.K., Broder K., et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep. 2008;57:1–60. [PubMed] [Google Scholar]
  • 12.Avery R.K., Michaels M. Update on immunizations in solid organ transplant recipients: what clinicians need to know. Am J Transplant. 2008;8:9–14. doi: 10.1111/j.1600-6143.2007.02051.x. [DOI] [PubMed] [Google Scholar]
  • 13.White-Williams C., Brown R., Kirklin J., et al. Improving clinical practice: should we give influenza vaccinations to heart transplant patients? J Heart Lung Transplant. 2006;25:320–323. doi: 10.1016/j.healun.2005.09.015. [DOI] [PubMed] [Google Scholar]
  • 14.Scharpe J., Evenepoel P., Maes B., et al. Influenza vaccination is efficacious and safe in renal transplant recipients. Am J Transplant. 2008;8:332–337. doi: 10.1111/j.1600-6143.2007.02066.x. [DOI] [PubMed] [Google Scholar]
  • 15.Lawal A., Basler C., Branch A., et al. Influenza vaccination in orthotopic liver transplant recipients: absence of post administration ALT elevation. Am J Transplant. 2004;4:1805–1809. doi: 10.1111/j.1600-6143.2004.00564.x. [DOI] [PubMed] [Google Scholar]
  • 16.Gangappa S., Kokko K.E., Carlson L.M., et al. Immune responsiveness and protective immunity after transplantation. Transpl Int. 2008;21:293–303. doi: 10.1111/j.1432-2277.2007.00631.x. [DOI] [PubMed] [Google Scholar]
  • 17.Madan R.P., Tan M., Fernandez-Sesma A., et al. A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings. Clin Infect Dis. 2008;46:712–718. doi: 10.1086/527391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Centers for Disease Control and Prevention: CDC Issues Interim Recommendations for the Use of Influenza Antiviral Medications in the Setting of Oseltamivir Resistance among Circulating Influenza A (H1N1) Viruses, 2008–09 Influenza Season. Available at http://www2a.cdc.gov/HAN/ArchiveSys/ViewMsgV.asp?AlertNum=00279. Accessed January 2009.
  • 19.Michaels MG, Fonseca-Aten M, Green M, et al.: Respiratory syncytial virus prophylaxis: a survey of pediatric solid organ transplant centers. Pediatr Transplant 2008 (Epub ahead of print). [DOI] [PubMed]
  • 20.Other herpesviruses: HHV-6, HHV-7, HHV-8, HSV-1 and -2, VZV. Am J Transplant 2004, 4(Suppl 10):66–71. [DOI] [PubMed]
  • 21.Cytomegalovirus. Am J Transplant 2004, 4(Suppl 10):51–58. [DOI] [PubMed]
  • 22.Torres-Madriz G., Boucher H.W. Immunocompromised hosts: perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients. Clin Infect Dis. 2008;47:702–711. doi: 10.1086/590934. [DOI] [PubMed] [Google Scholar]
  • 23.Miller G.G., Dummer J.S. Herpes simplex and varicella zoster viruses: forgotten but not gone. Am J Transplant. 2007;7:741–747. doi: 10.1111/j.1600-6143.2006.01718.x. [DOI] [PubMed] [Google Scholar]
  • 24.Kalil A.C., Levitsky J., Lyden E., et al. Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients. Ann Intern Med. 2005;143:870–880. doi: 10.7326/0003-4819-143-12-200512200-00005. [DOI] [PubMed] [Google Scholar]
  • 25.Paya C., Humar A., Dominguez E., et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant. 2004;4:611–620. doi: 10.1111/j.1600-6143.2004.00382.x. [DOI] [PubMed] [Google Scholar]
  • 26.Zamora M.R., Davis R.D., Leonard C. Management of cytomegalovirus infection in lung transplant recipients: evidence-based recommendations. Transplantation. 2005;80:157–163. doi: 10.1097/01.TP.0000165430.65645.4F. [DOI] [PubMed] [Google Scholar]
  • 27.Silveira F.P., Husain S. Fungal infections in solid organ transplantation. Med Mycol. 2007;45:305–320. doi: 10.1080/13693780701200372. [DOI] [PubMed] [Google Scholar]
  • 28.Pneumocystis jiroveci (formerly Pneumocystis carinii). Am J Transplant 2004, 4(Suppl 10):135–141. [DOI] [PubMed]
  • 29.Grossi P., Farina C., Fiocchi R., Dalla Gasperina D. Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients. Transplantation. 2000;70:112–116. [PubMed] [Google Scholar]
  • 30.Singh N., Husain S. Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management. J Heart Lung Transplant. 2003;22:258–266. doi: 10.1016/S1053-2498(02)00477-1. [DOI] [PubMed] [Google Scholar]
  • 31.Montoya J.G., Chaparro S.V., Celis D., et al. Invasive aspergillosis in the setting of cardiac transplantation. Clin Infect Dis. 2003;37(Suppl3):S281–S292. doi: 10.1086/376527. [DOI] [PubMed] [Google Scholar]
  • 32.Singh N., Avery R.K., Munoz P., et al. Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin Infect Dis. 2003;36:46–52. doi: 10.1086/345441. [DOI] [PubMed] [Google Scholar]
  • 33.Cornet M., Fleury L., Maslo C., et al. Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area. J Hosp Infect. 2002;51:288–296. doi: 10.1053/jhin.2002.1258. [DOI] [PubMed] [Google Scholar]
  • 34.Husain S., Alexander B.D., Munoz P., et al. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis. 2003;37:221–229. doi: 10.1086/375822. [DOI] [PubMed] [Google Scholar]
  • 35.Husain S., Munoz P., Forrest G., et al. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin Infect Dis. 2005;40:89–99. doi: 10.1086/426445. [DOI] [PubMed] [Google Scholar]
  • 36.Kauffman C.A. Zygomycosis: reemergence of an old pathogen. Clin Infect Dis. 2004;39:588–590. doi: 10.1086/422729. [DOI] [PubMed] [Google Scholar]
  • 37.Vilchez R.A., Fung J., Kusne S. Cryptococcosis in organ transplant recipients: an overview. Am J Transplant. 2002;2:575–580. doi: 10.1034/j.1600-6143.2002.20701.x. [DOI] [PubMed] [Google Scholar]
  • 38.Silveira F.P., Husain S., Kwak E.J., et al. Cryptococcosis in liver and kidney transplant recipients receiving anti-thymocyte globulin or alemtuzumab. Transpl Infect Dis. 2007;9:22–27. doi: 10.1111/j.1399-3062.2006.00149.x. [DOI] [PubMed] [Google Scholar]
  • 39.Blair J.E., Logan J.L. Coccidioidomycosis in solid organ transplantation. Clin Infect Dis. 2001;33:1536–1544. doi: 10.1086/323463. [DOI] [PubMed] [Google Scholar]
  • 40.Blair J.E., Douglas D.D. Coccidioidomycosis in liver transplant recipients relocating to an endemic area. Dig Dis Sci. 2004;49:1981–1985. doi: 10.1007/s10620-004-9605-0. [DOI] [PubMed] [Google Scholar]
  • 41.Vail G.M., Young R.S., Wheat L.J., et al. Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area. Transpl Infect Dis. 2002;4:148–151. doi: 10.1034/j.1399-3062.2002.01016.x. [DOI] [PubMed] [Google Scholar]
  • 42.Strategies for safe living following solid organ transplantation. Am J Transplant 2004, 4(Suppl 10):156–159. [DOI] [PubMed]
  • 43.Praz-Christinaz S.M., Lazor-Blanchet C., Binet I., et al. Occupational risk assessment of aspergillosis after renal transplantation. Transpl Infect Dis. 2007;9:175–181. doi: 10.1111/j.1399-3062.2007.00223.x. [DOI] [PubMed] [Google Scholar]
  • 44.Walsh T.R., Guttendorf J., Dummer S., et al. The value of protective isolation procedures in cardiac allograft recipients. Ann Thorac Surg. 1989;47:539–544. doi: 10.1016/0003-4975(89)90429-3. [DOI] [PubMed] [Google Scholar]
  • 45.Fortun J., Martin-Davila P., Moreno S., et al. Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients. J Antimicrob Chemother. 2003;52:813–819. doi: 10.1093/jac/dkg450. [DOI] [PubMed] [Google Scholar]
  • 46.Tollemar J., Hockerstedt K., Ericzon B.G., et al. Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized, placebo-controlled study. Transplantation. 1995;59:45–50. doi: 10.1097/00007890-199501150-00009. [DOI] [PubMed] [Google Scholar]
  • 47.Corcoran T.E., Venkataramanan R., Mihelc K.M., et al. Aerosol deposition of lipid complex amphotericin-B (Abelcet) in lung transplant recipients. Am J Transplant. 2006;6:2765–2773. doi: 10.1111/j.1600-6143.2006.01529.x. [DOI] [PubMed] [Google Scholar]
  • 48.Husain S., Paterson D.L., Studer S., et al. Voriconazole prophylaxis in lung transplant recipients. Am J Transplant. 2006;6:3008–3016. doi: 10.1111/j.1600-6143.2006.01548.x. [DOI] [PubMed] [Google Scholar]
  • 49.Blair J.E. Approach to the solid organ transplant patient with latent infection and disease caused by Coccidioides species. Curr Opin Infect Dis. 2008;21:415–420. doi: 10.1097/QCO.0b013e3283073828. [DOI] [PubMed] [Google Scholar]
  • 50.Kowalski R.J., Post D.R., Mannon R.B., et al. Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation. 2006;82:663–668. doi: 10.1097/01.tp.0000234837.02126.70. [DOI] [PubMed] [Google Scholar]

Articles from Current Infectious Disease Reports are provided here courtesy of Nature Publishing Group

RESOURCES